Role of the lipoperoxidation product 4-hydroxynonenal in the pathogenesis of severe malaria anemia and malaria immunodepression

Oxidative Medicine and Cellular Longevity

Volumn 2015, Issue , 2015, Pages

  Schwarzer, Evelin ^a   Arese, Paolo ^a   Skorokhod, Oleksii A ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL PROPERTIES; MOLECULES; OXIDATIVE STRESS; PHOSPHOLIPIDS;

4-HYDROXY-NONENAL; CELL FUNCTIONS; DIFFUSIBLE MOLECULES; FALCIPARUM MALARIA; LIPOPEROXIDATION; LOW CONCENTRATIONS; OXIDATIVE STRESS MARKERS; PATHOGENIC FACTORS;

DISEASES;

4 HYDROXYNONENAL; BIOLOGICAL MARKER; MEMBRANE PROTEIN; MEMBRANE RECEPTOR; 4-HYDROXY-2-NONENAL; ALDEHYDE;

ANEMIA; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL MATURATION; DENDRITIC CELL; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; LIPID PEROXIDATION; MALARIA; MALARIA FALCIPARUM; MOLECULAR PATHOLOGY; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PHAGOCYTE; PHAGOCYTOSIS; REVIEW; CHEMISTRY; COMPLICATION; CYTOLOGY; ERYTHROCYTE; IMMUNOLOGY; METABOLISM; PATHOLOGY;

ALDEHYDES; ANEMIA; DENDRITIC CELLS; ERYTHROCYTES; HUMANS; LIPID PEROXIDATION; MALARIA;

EID: 84929359331     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2015/638416     Document Type: Review

References (72)

1. S. Percário, D. R. Moreira, B. A. Q. Gomes et al. , "Oxidative stress in Malaria, " International Journal of Molecular Sciences, vol. 13, no. 12, pp. 16346-16372, 2012.
2. K. Becker, L. Tilley, J. L. Vennerstrom, D. Roberts, S. Rogerson, and H. Ginsburg, "Oxidative stress in malaria parasite-infected erythrocytes: host-parasite interactions, " International Journal for Parasitology, vol. 34, no. 2, pp. 163-189, 2004.
3. L. Luzzatto, E. A. Usanga, and S. Reddy, "Glucose-6-phosphate dehydrogenase deficient red cells: resistance to infection by malarial parasites, " Science, vol. 164, no. 3881, pp. 839-842, 1969.
4. M. Cappadoro, G. Giribaldi, E. O'Brien et al. , "Early phagocytosis of glucose-6-phosphate dehydrogenase (G6PD)-deficient erythrocytes parasitized by Plasmodium falciparum may explain malaria protection in G6PD deficiency, " Blood, vol. 92, no. 7, pp. 2527-2534, 1998.
5. J. F. Kun, B. Mordmüller, D. J. Perkins et al. , "Nitric oxide synthase 2(Lambaréné) (G-954C), increased nitric oxide production, and protection against malaria, " The Journal of Infectious Diseases, vol. 184, no. 3, pp. 330-336, 2001.
6. A. M. Taylor, N. P. J. Day, D. X. T. Sinh et al. , "Reactive nitrogen intermediates and outcome in severe adult malaria, " Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 92, no. 2, pp. 170-175, 1998.
7. B. S. Das, D. I. Thurnham, J. K. Patnaik, D. B. Das, R. Satpathy, and T. K. Bose, "Increased plasma lipid peroxidation in riboflavin-deficient, malaria-infected children, " The American Journal of Clinical Nutrition, vol. 51, no. 5, pp. 859-863, 1990.
8. B. S. Das and N. K. Nanda, "Evidence for erythrocyte lipid pepoxidation in acute falciparum malaria, " Transactions of the Royal Society of TropicalMedicine andHygiene, vol. 93, no. 1, pp. 58-62, 1999.
9. R. Aguilar, T. Marrocco, O. A. Skorokhodet al. , "Bloodoxidative stress markers and Plasmodium falciparum malaria in nonimmune African children, " British Journal of Haematology, vol. 164, no. 3, pp. 438-450, 2014.
10. G. Poli, R. J. Schaur, W. G. Siems, and G. Leonarduzzi, "4-Hydroxynonenal: a membrane lipid oxidation product of medicinal interest, " Medicinal Research Reviews, vol. 28, no. 4, pp. 569-631, 2008.
11. R. J. Schaur, "Basic aspects of the biochemical reactivity of 4-hydroxynonenal, " Molecular Aspects of Medicine, vol. 24, no. 4-5, pp. 149-159, 2003.
12. H. W. Gardner, "Oxygen radical chemistry of polyunsaturated fatty acids, " Free Radical Biology and Medicine, vol. 7, no. 1, pp. 65-86, 1989.
13. Z. Wang, "Hock rearrangement, " in Comprehensive Organic Name Reactions and Reagents, John Wiley & Sons, New York, NY, USA, 2010.
14. R. Subramaniam, F. Roediger, B. Jordan et al. , "The lipid peroxidation product, 4-hydroxy-2-trans-nonenal, alters the conformation of cortical synaptosomal membrane proteins, " Journal of Neurochemistry, vol. 69, no. 3, pp. 1161-1169, 1997.
15. A. Castegna, C. M. Lauderback, H. Mohmmad-Abdul, and D. A. Butterfield, "Modulation of phospholipid asymmetry in synaptosomal membranes by the lipid peroxidation products, 4-hydroxynonenal and acrolein: implications for Alzheimer's disease, " Brain Research, vol. 1004, no. 1-2, pp. 193-197, 2004.
16. K. Uchida, "4-hydroxy-2-nonenal: a product and mediator of oxidative stress, " Progress in Lipid Research, vol. 42, no. 4, pp. 318-343, 2003.
17. C. K. Winter, H. J. Segall, and W. F. Haddon, "Formation of cyclic adducts of deoxyguanosine with the aldehydes trans-4-hydroxy-2-hexenal and trans-4-hydroxy-2-nonenal in vitro, " Cancer Research, vol. 46, no. 11, pp. 5682-5686, 1986.
18. F.-L. Chung, H.-J. C. Chen, J. B. Guttenplan, A. Nishikawa, and G. C. Hard, "2, 3-epoxy-4-hydroxynonanal as a potential tumorinitiating agent of lipid peroxidation, " Carcinogenesis, vol. 14, no. 10, pp. 2073-2077, 1993.
19. M. Guichardant, P. Taibi-Tronche, L. B. Fay, and M. Lagarde, "Covalent modifications of aminophospholipids by 4-hydroxynonenal, " Free Radical Biology and Medicine, vol. 25, no. 9, pp. 1049-1056, 1998.
20. M. Guichardant, N. Bernoud-Hubac, B. Chantegrel, C. Deshayes, and M. Lagarde, "Aldehydes from n-6 fatty acid peroxidation. Effects on aminophospholipids, " Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 67, no. 2-3, pp. 147-149, 2002.
21. S. Bacot, N. Bernoud-Hubac, N. Baddas et al. , "Covalent binding of hydroxy-alkenals 4-HDDE, 4-HHE, and 4-HNE to ethanolamine phospholipid subclasses, " Journal of Lipid Research, vol. 44, no. 5, pp. 917-926, 2003.
22. J. Sowell, B. Frei, and J. F. Stevens, "Vitamin C conjugates of genotoxic lipid peroxidation products: structural characterization and detection in human plasma, " Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 52, pp. 17964-17969, 2004.
23. V. Amarnath, K. Amarnath, K. Amarnath, S. Davies, and L. J. Roberts II, "Pyridoxamine: an extremely potent scavenger of 1, 4-dicarbonyls, " Chemical Research in Toxicology, vol. 17, no. 3, pp. 410-415, 2004.
24. W. G. Siems, H. Zollner, T. Grune, and H. Esterbauer, "Metabolic fate of 4-hydroxynonenal in hepatocytes: 1, 4-dihydroxynonene is not the main product, " Journal of Lipid Research, vol. 38, no. 3, pp. 612-622, 1997.
25. H. Esterbauer, H. Zollner, and J. Lang, "Metabolism of the lipid peroxidation product 4-hydroxynonenal by isolated hepatocytes and by liver cytosolic fractions, " Biochemical Journal, vol. 228, no. 2, pp. 363-373, 1985.
26. W. Siems and T. Grune, "Intracellular metabolism of 4-hydroxynonenal, " Molecular Aspects of Medicine, vol. 24, no. 4-5, pp. 167-175, 2003.
27. H. Esterbauer, R. J. Schaur, and H. Zollner, "Chemistry and Biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes, " Free Radical Biology and Medicine, vol. 11, no. 1, pp. 81-128, 1991.
28. E. Schwarzer, O. Müller, P. Arese, W. G. Siems, and T. Grune, "Increased levels of 4-hydroxynonenal in humanmonocytes fed with malarial pigment hemozoin. A possible clue for hemozoin toxicity, " FEBS Letters, vol. 388, no. 2-3, pp. 119-122, 1996.
29. G. Witz, N. J. Lawrie, M. A. Amoruso, and B. D. Goldstein, "Inhibition by reactive aldehydes of superoxide anion radical production from stimulated polymorphonuclear leukocytes and pulmonary alveolar macrophages. Effects on cellular sulfhydryl groups and NADPH oxidase activity, " Biochemical Pharmacology, vol. 36, no. 5, pp. 721-726, 1987.
30. T. Wagner, J. Mullally, and F. A. Fitzpatrick, "Reactive lipid species from cyclooxygenase-2 inactivate tumor suppressor LKB1/S TK11. Cyclopentenone prostaglandins and 4-hydroxy-2-nonenal covalently modify and inhibit the AMP-kinase kinase that modulates cellular energy homeostasis and protein translation, " The Journal of Biological Chemistry, vol. 281, pp. 2598-2604, 2006.
31. K. S. Echtay, T. C. Esteves, J. L. Pakay et al. , "A signalling role for 4-hydroxy-2-nonenal in regulation of mitochondrial uncoupling, " EMBO Journal, vol. 22, no. 16, pp. 4103-4110, 2003.
32. K. K. Andringa, U. S. Udoh, A. Landar, and S. M. Bailey, "Proteomic analysis of 4-hydroxynonenal (4-HNE) modified proteins in liver mitochondria from chronic ethanol-fed rats, " Redox Biology, vol. 2, pp. 1038-1047, 2014.
33. E. A. Perry, R. J. Castellani, P. I. Moreira et al. , "Neurofilaments are the major neuronal target of hydroxynonenal-mediated protein cross-links, " Free Radical Research, vol. 47, no. 6-7, pp. 507-510, 2013.
34. F. Khatoon, Moinuddin, K. Alam, and A. Ali, "Physicochemical and immunological studies on 4-hydroxynonenal modified HSA: implications of protein damage by lipid peroxidation products in the etiopathogenesis of SLE, " Human Immunology, vol. 73, no. 11, pp. 1132-1139, 2012.
35. R. L. Smathers, K. S. Fritz, J. J. Galligan et al. , "Characterization of 4-HNE modified L-FABP reveals alterations in structural and functional dynamics, " PLoSONE, vol. 7, no. 6, Article IDe38459, 2012.
36. S. Pizzimenti, S. Laurora, F. Briatore, C. Ferretti, M. U. Dianzani, and G. Barrera, "Synergistic effect of 4-hydroxynonenal and PPAR ligands in controlling human leukemic cell growth and differentiation, " Free Radical Biology and Medicine, vol. 32, no. 3, pp. 233-245, 2002.
37. T. Ishii, K. Itoh, E. Ruiz et al. , "Role of Nrf2 in the regulation of CD36 and stress protein expression in murine macrophages: activation by oxidativelymodified LDL and 4-hydroxynonenal, " Circulation Research, vol. 94, no. 5, pp. 609-616, 2004.
38. H. Minekura, T. Kumagai, Y. Kawamoto, F. Nara, andK. Uchida, "4-Hydroxy-2-nonenal is a powerful endogenous inhibitor of endothelial response, " Biochemical and Biophysical Research Communications, vol. 282, no. 2, pp. 557-561, 2001.
39. T. Grune, P. Michel, N. Sitte et al. , "Increased levels of 4-hydroxynonenal modified proteins in plasma of children with autoimmune diseases, " Free Radical Biology and Medicine, vol. 23, no. 3, pp. 357-360, 1997.
40. W. Siems, F. Carluccio, S. Radenkovic, T. Grune, and H. Hampl, "Oxidative stress in renal anemia of hemodialysis patients is mitigated by epoetin treatment, " Kidney and Blood Pressure Research, vol. 28, no. 5-6, pp. 295-301, 2006.
41. G. D. Buffinton, N. H. Hunt, W. B. Cowden, and I. A. Clark, "Detection of short-chain carbonyl products of lipid peroxidation from malaria-parasite (Plasmodium vinckei)-infected red blood cells exposed to oxidative stress, " Biochemical Journal, vol. 249, no. 1, pp. 63-68, 1988.
42. I. A. Clark, G. A. Butcher, G. D. Buffinton, N. H. Hunt, andW. B. Cowden, "Toxicity of certain products of lipid peroxidation to the human malaria parasite Plasmodium falciparum, " Biochemical Pharmacology, vol. 36, no. 4, pp. 543-546, 1987.
43. B. S. Das, J. K. Patnaik, S. Mohanty et al. , "Plasma antioxidants and lipid peroxidation products in falciparum malaria, " The American Journal of Tropical Medicine and Hygiene, vol. 49, no. 6, pp. 720-725, 1993.
44. M. C. Delmas-Beauvieux, E. Peuchant, M. F. Dumon, M. C. Receveur, M. Le Bras, andM. Clerc, "Relationship between red blood cell antioxidant enzymatic system status and lipoperoxidationduring the acute phase ofmalaria, " Clinical Biochemistry, vol. 28, no. 2, pp. 163-169, 1995.
45. O. Erel, H. Vural, N. Aksoy, G. Aslan, and M. Ulukanligil, "Oxidative stress of platelets and thrombocytopenia in patients with vivaxmalaria, " Clinical Biochemistry, vol. 34, no. 4, pp. 341-344, 2001.
46. S. H. Tiyong Ifoue, C. Teugwa Mofor, I. Gouado, G. Teto, T. Asonganyi, and P. H. Amvam Zollo, "Evaluation of oxidative stress and antioxidant status of pregnant women suffering from malaria in Cameroon, " Indian Journal of Clinical Biochemistry, vol. 24, no. 3, pp. 288-293, 2009.
47. S. Kapishnikov, A. Weiner, E. Shimoni et al. , "Oriented nucleation of hemozoin at the digestive vacuole membrane in Plasmodium falciparum, " Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 28, pp. 11188-11193, 2012.
48. C. M. Miller, C. K. Carney, A. C. Schrimpe, and D. W. Wright, "-hematin (hemozoin) mediated decompostion of polyunsaturated fatty acids to 4-hydroxy-2-nonenal, " Inorganic Chemistry, vol. 44, no. 7, pp. 2134-2136, 2005.
49. C. M. Spickett, "The lipid peroxidation product 4-hydroxy-2-nonenal: advances in chemistry and analysis, " Redox Biology, vol. 1, no. 1, pp. 145-152, 2013.
50. G. Waeg, G. Dimsity, andH. Esterbauer, "Monoclonal antibodies for detection of 4-hydroxynonenal modified proteins, " Free Radical Research, vol. 25, no. 2, pp. 149-159, 1996.
51. S. Uyoga, O. A. Skorokhod, M. Opiyo et al. , "Transfer of 4-hydroxynonenal from parasitized to non-parasitized erythrocytes in rosettes. Proposed role in severe malaria anemia, " British Journal of Haematology, vol. 157, no. 1, pp. 116-124, 2012.
52. O. Skorokhod, E. Schwarzer, T. Grune, and P. Arese, "Role of 4-hydroxynonenal in the hemozoin-mediated inhibition of differentiation of human monocytes to dendritic cells induced by GM-CSF/IL-4, " BioFactors, vol. 24, no. 1-4, pp. 283-289, 2005.
53. V. Barrera, O. A. Skorokhod, D. Baci, G. Gremo, P. Arese, and E. Schwarzer, "Host fibrinogen stably bound to hemozoin rapidly activates monocytes via TLR-4 and CD11b/CD18-integrin: a new paradigm of hemozoin action, " Blood, vol. 117, no. 21, pp. 5674-5682, 2011.
54. E. Schwarzer, F. Turrini, D. Ulliers, G. Giribaldi, H. Ginsburg, and P. Arese, "Impairment of macrophage functions after ingestion of Plasmodium falciparum-infected erythrocytes or isolated malarial pigment, " Journal of Experimental Medicine, vol. 176, no. 4, pp. 1033-1041, 1992.
55. A. Tyberghein, K. Deroost, E. Schwarzer, P. Arese, and P. E. Van den Steen, "Immunopathological effects of malaria pigment or hemozoin and other crystals, " BioFactors, vol. 40, no. 1, pp. 59-78, 2014.
56. E. Schwarzer, O. A. Skorokhod, V. Barrera, and P. Arese, "Hemozoin and the human monocyte-a brief review of their interactions, " Parassitologia, vol. 50, no. 1-2, pp. 143-145, 2008.
57. O. A. Skorokhod, M. Alessio, B. Mordmüller, P. Arese, and E. Schwarzer, "Hemozoin (malarial pigment) inhibits differentiation and maturation of human monocyte-derived dendritic cells: a peroxisome proliferator-activated receptor-mediated effect, " The Journal of Immunology, vol. 173, no. 6, pp. 4066-4074, 2004.
58. B. C. Urban, T. Mwangi, A. Ross et al. , "Peripheral blood dendritic cells in children with acute Plasmodium falciparum malaria, " Blood, vol. 98, no. 9, pp. 2859-2861, 2001.
59. E. Schwarzer, F. Turrini, G. Giribaldi, M. Cappadoro, and P. Arese, "Phagocytosis of P. falciparum malarial pigment hemozoin by human monocytes inactivates monocyte protein kinase C, " Biochimica et Biophysica Acta-Molecular Basis of Disease, vol. 1181, no. 1, pp. 51-54, 1993.
60. A. C. Schrimpe and D. W. Wright, "Comparative analysis of gene expression changesmediated by individual constituents of hemozoin, " Chemical Research in Toxicology, vol. 22, no. 3, pp. 433-445, 2009.
61. S. H. Benedict, K. M. Cool, A. L. Dotson, and M. A. Chan, "Immune accessory proteins, " in Encyclopedia of Life Sciences, John Wiley & Sons, 2007, http://onlinelibrary. wiley. com/doi/10. 1002/9780470015902. a0000923. pub2/full.
62. M. Ricote, J. T. Huang, J. S. Welch, andC. K. Glass, "The peroxisome proliferator-activated receptor (PPAR) as a regulator of monocyte/macrophage function, " Journal of Leukocyte Biology, vol. 66, no. 5, pp. 733-739, 1999.
63. X. Zhang and H. A. Young, "PPAR and immune system-what do we know" International Immunopharmacology, vol. 2, no. 8, pp. 1029-1044, 2002.
64. T. D. Gilmore, "Introduction to NF-B: players, pathways, perspectives, " Oncogene, vol. 25, no. 51, pp. 6680-6684, 2006.
65. J. A. Chasis and N. Mohandas, "Erythroblastic islands: niches for erythropoiesis, " Blood, vol. 112, no. 3, pp. 470-478, 2008.
66. C. Casals-Pascual, O. Kai, J. O. P. Cheung et al. , "Suppression of erythropoiesis in malarial anemia is associated with hemozoin in vitro and in vivo, " Blood, vol. 108, no. 8, pp. 2569-2577, 2006.
67. R. Aguilar, C. Moraleda, A. H. Achtman et al. , "Severity of anaemia is associated with bone marrow haemozoin in children exposed to Plasmodium falciparum, " British Journal of Haematology, vol. 164, no. 6, pp. 877-887, 2014.
68. G. Giribaldi, D. Ulliers, E. Schwarzer, I. Roberts, W. Piacibello, and P. Arese, "Hemozoin-and 4-hydroxynonenal-mediated inhibition of erythropoiesis. Possible role in malarial dyserythropoiesis and anemia, " Haematologica, vol. 89, no. 4, pp. 492-493, 2004.
69. O. A. Skorokhod, L. Caione, T. Marrocco et al. , "Inhibition of erythropoiesis in malaria anemia: Role of hemozoin and hemozoin-generated 4-hydroxynonenal, " Blood, vol. 116, no. 20, pp. 4328-4337, 2010.
70. D. Méndez, M. L. Hernaéz, A. N. Kamali, A. Diez, A. Puyet, and J. M. Bautista, "Differential carbonylation of cytoskeletal proteins in blood groupOerythrocytes: potential role in protection against severemalaria, " Infection, Genetics and Evolution, vol. 12, no. 8, pp. 1780-1787, 2012.
71. O. A. Skorokhod, V. Barrera, R. Heller et al. , "Malarial pigment hemozoin impairs chemotactic motility and transendothelial migration of monocytes via 4-hydroxynonenal, " Free Radical Biology and Medicine, vol. 75, pp. 210-221, 2014.
72. G. Zhang, O. A. Skorokhod, S. K. Khoo et al. , "Plasma advanced oxidative protein products are associated with anti-oxidative stress pathway genes and malaria in a longitudinal cohort, " Malaria Journal, vol. 13, article 134, 2014.